bearish
SciClone Pharmaceuticals: Caged by the Elephant
297 Views08 Feb 2021 23:24
SciClone Pharmaceuticals is a China-based company that has filed to list on the HKEX. We expect concerns about VBP for Zadaxin to weigh on the valuation for some time. We would pass on the deal.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Kemp Dolliver, CFA
Founder
Price Chart(Sign Up to Access)
- SciClone Pharmaceuticals: Caged by the Elephant08 Feb 2021
- SciClone Pharma (赛生药业) Pre-IPO: PHIP Updates and Thoughts on Valuation02 Feb 2021
- China Healthcare: Macro Themes18 Dec 2020
- Asian Healthcare - Coming of Age26 Nov 2020
x